» Articles » PMID: 33562261

Significant Changes in Serum MicroRNAs After High Tibial Osteotomy in Medial Compartmental Knee Osteoarthritis: Potential Prognostic Biomarkers

Overview
Specialty Radiology
Date 2021 Feb 10
PMID 33562261
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

High tibial osteotomy (HTO) is an effective alternative for medial compartmental knee osteoarthritis (OA). Circulating microRNAs (miRNAs) are known to serve as OA-related biomarkers. The present study investigated the differential expression of serum miRNAs before and after HTO to identify potential miRNAs as prognostic biomarkers. miRNA-polymerase chain reaction (PCR) arrays were used to screen for miRNAs in the serum at preoperative and 6-month postoperative time points from six patients, and the differentially expressed miRNAs identified in the profiling stage were validated using real-time PCR at post-operative months 6 and 18 in 27 other HTO-treated patients. Among 84 miRNAs involved in the inflammatory process, three (miR-19b-3p, miR-29c-3p, and miR-424-5p) showed differential expression patterns in the profiling stage ( = 0.011, 0.015, and 0.021, respectively). Levels of these three and four other miRNAs (miR-140-3p, miR-454-3p, miR-let-7e-5p, and miR-885-5p) known to be related to OA progression were evaluated in the serum of 27 patients. Only four miRNAs (miR-19b-3p, miR-140-3p, miR-454-3p, and miR-let-7e-5p) were significantly upregulated at postoperative month 6 ( = 0.003, 0.005, 0.004, and 0.004, respectively), and only miR-140-3p was significantly upregulated up to 18 months after operation ( = 0.003). Together, this study reveals the significantly upregulated serum miRNAs after HTO as potential prognostic biomarkers; however, further studies are warranted to elucidate their clinical implications.

Citing Articles

Exosomes from osteoarthritic fibroblast-like synoviocytes promote cartilage ferroptosis and damage via delivering microRNA-19b-3p to target SLC7A11 in osteoarthritis.

Kong R, Ji L, Pang Y, Zhao D, Gao J Front Immunol. 2023; 14:1181156.

PMID: 37691947 PMC: 10484587. DOI: 10.3389/fimmu.2023.1181156.


miR-140-5p and miR-140-3p: Key Actors in Aging-Related Diseases?.

Toury L, Frankel D, Airault C, Magdinier F, Roll P, Kaspi E Int J Mol Sci. 2022; 23(19).

PMID: 36232738 PMC: 9570089. DOI: 10.3390/ijms231911439.

References
1.
Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini M, Clark I . The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 2006; 580(17):4214-7. DOI: 10.1016/j.febslet.2006.06.080. View

2.
Reid G, Kirschner M, van Zandwijk N . Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol. 2010; 80(2):193-208. DOI: 10.1016/j.critrevonc.2010.11.004. View

3.
Shao N, Xue L, Wang R, Luo K, Zhi F, Lan Q . miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor Suppressor in Glioma. Mol Cancer Ther. 2018; 18(2):459-469. DOI: 10.1158/1535-7163.MCT-18-0725. View

4.
Li Y, Tavallaee G, Tokar T, Nakamura A, Sundararajan K, Weston A . Identification of synovial fluid microRNA signature in knee osteoarthritis: differentiating early- and late-stage knee osteoarthritis. Osteoarthritis Cartilage. 2016; 24(9):1577-86. DOI: 10.1016/j.joca.2016.04.019. View

5.
Lin L, Shen Q, Zhang C, Chen L, Yu C . Assessment of the profiling microRNA expression of differentiated and dedifferentiated human adult articular chondrocytes. J Orthop Res. 2011; 29(10):1578-84. DOI: 10.1002/jor.21423. View